Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

K. M. Kerr, U. Dafni, K. Schulze, E. Thunnissen, L. Bubendorf, H. Hager, S. Finn, W. Biernat, L. Vliegen, J. H. Losa, A. Marchetti, R. Cheney, A. Warth, E. -J. Speel, F. Blackhall, K. Monkhorst, E. Jantus Lewintre, V. Tischler, C. Clark, J. Bertran-AlamilloP. Meldgaard, K. Gately, A. Wrona, P. Vandenberghe, E. Felip, G. De Luca, S. Savic, T. Muley, E. F. Smit, A. -M. C. Dingemans, L. Priest, P. Baas, C. Camps, W. Weder, V. Polydoropoulou, T. R. Geiger, R. Kammler, T. Sumiyoshi, M. A. Molina, D. S. Shames, R. A. Stahel, S. Peters, Etop Lungscape Consortium

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)200-208
Number of pages9
JournalAnnals of Oncology
Volume29
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • non-small-cell lung cancer
  • multiplex mutation analysis
  • EGFR
  • KRAS
  • PIK3CA
  • prognosis molecular staging
  • CELL LUNG-CANCER
  • TYROSINE KINASE INHIBITORS
  • PREDICT SURVIVAL
  • KRAS MUTATIONS
  • ADENOCARCINOMA
  • OVEREXPRESSION
  • HETEROGENEITY
  • AMPLIFICATION
  • VALIDATION

Cite this

Kerr, K. M., Dafni, U., Schulze, K., Thunnissen, E., Bubendorf, L., Hager, H., Finn, S., Biernat, W., Vliegen, L., Losa, J. H., Marchetti, A., Cheney, R., Warth, A., Speel, E. -J., Blackhall, F., Monkhorst, K., Lewintre, E. J., Tischler, V., Clark, C., ... Etop Lungscape Consortium (2018). Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project. Annals of Oncology, 29(1), 200-208. https://doi.org/10.1093/annonc/mdx629